Jim Cramer Says Elon Musk Has Accomplished The Impossible: 'One Of The Greatest Minds Ever'
Portfolio Pulse from Adam Eckert
Elon Musk's Neuralink has successfully performed its first human implant procedure, with the patient recovering well. The FDA approved Neuralink's first in-human clinical study in May 2023. The device, named 'Telepathy,' is designed to help paralysis patients control devices through thought. Jim Cramer praised the achievement on CNBC, contrasting it with his recent skepticism towards Tesla (NASDAQ:TSLA), and suggested that Musk could be recognized as one of the greatest minds ever for this advancement.
January 30, 2024 | 8:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer, who has been critical of Tesla stock recently, acknowledged the significant achievement of Musk's Neuralink, potentially influencing investor perception positively.
Cramer's recognition of Musk's success with Neuralink could improve investor sentiment towards Musk's ventures, including Tesla. Although Neuralink is separate from Tesla, the positive news could indirectly benefit TSLA's stock in the short term as it reflects on Musk's overall reputation as an innovator.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70